SECOND GENOME
Second Genome’s mission is to transform lives with medicines developed through innovative microbiome science. Second Genome has built a novel platform for microbiome drug discovery. Second Genome has completed more than 400 microbiome studies, analyzing more than 75,000 samples, for internal R&D, as well as for external partners across government, academia, pharmaceutical, nutrition and industrial companies. The team leverages its microbiome analysis platform with its partners’ specific expe... rtise to generate insightful findings that can accelerate research programs by elucidating the role of the microbiome in human health conditions, agriculture, animal health and other industries. The company has established a pipeline of therapeutic products for the treatment of inflammation and metabolic diseases.
SECOND GENOME
Industry:
Biotechnology Health Diagnostics Medical
Founded:
2009-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.secondgenome.com
Total Employee:
11+
Status:
Active
Contact:
9253973170
Email Addresses:
[email protected]
Total Funding:
62.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Vero Biotech
Vero Biotech is a biopharmaceutical company developing products to address the medical needs of patients with pulmonary, cardiac diseases.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Morgenthaler Ventures
Morgenthaler Ventures investment in Series B - Second Genome
Mayo Clinic
Mayo Clinic investment in Series B - Second Genome
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - Second Genome
Lifeforce Capital
Lifeforce Capital investment in Series B - Second Genome
Advanced Technology Ventures
Advanced Technology Ventures investment in Series B - Second Genome
SR One
SR One investment in Series B - Second Genome
Seraph Group
Seraph Group investment in Series B - Second Genome
Digitalis Ventures
Digitalis Ventures investment in Series B - Second Genome
MBLVC
MBLVC investment in Series B - Second Genome
Roche Venture Fund
Roche Venture Fund investment in Series B - Second Genome
Newest Events participated
Participated in 3rd Annual Translational Microbiome Conference
on 2017-04-11 as sponsor
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-19 | Second Genome Appoints Joseph Dal Porto, Ph.D., as Chief Scientific Officer |
Official Site Inspections
http://www.secondgenome.com Semrush global rank: 2.51 M Semrush visits lastest month: 7 K
- Host name: vps57573.dreamhostps.com
- IP address: 75.119.221.7
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
